Pancreatic cancer mortality among men in the US is projected to increase from 15.8 in 2024 to 16.7 per 100,000 by 2028. This shows a consistent upward trend with a compound annual growth rate of approximately 1.4% over five years. Notably, this increase follows an established pattern from prior years, reflecting persistent challenges in treating and preventing this deadly disease.
Future trends to watch for include advancements in early diagnosis and treatment, which could potentially alter mortality rates. Additionally, lifestyle changes and public health interventions aimed at mitigating risk factors may contribute to future trends.
